Physician profile
Anthony S Gordon
NPI 1811983380
$17,259.78
in general payments reported to CMS, 2019-2025
13 companies · $67.58 in 2025
The $67.58 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,227 · 2020: $248 · 2021: $13K · 2025: $67.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $67.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $67.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lima USA, INC. | $11,691.11 | 2019-2021 | |
| Stryker Corporation | $1,535.82 | 2019-2021 | |
| Limacorporate S.P.A. | $1,096.46 | 2021 | |
| Arthrex, INC. | $986.12 | 2019 | |
| Depuy Synthes Sales INC. | $632.75 | 2019-2020 | |
| Active Medical, LLC | $507.52 | 2019 | |
| Medical Device Business Services, INC. | $495.39 | 2019 | |
| Zimmer Biomet Holdings, INC. | $115.24 | 2021-2025 | Samples Biologics |
| Smith+Nephew, INC. | $102.53 | 2019-2021 | |
| Vericel Corporation | $47.65 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $20.87 | 2021 | |
| Sanofi-Aventis U.S. LLC | $17.50 | 2019 | |
| Ferring Pharmaceuticals INC. | $10.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.